Live Breaking News & Updates on Aarti Speciality Chemicals
Stay updated with breaking news from Aarti speciality chemicals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Aarti Speciality Chemicals, a wholly-owned subsidiary of Aarti Drugs (Aarti Drugs), stands out to be one of the beneficiaries of the Government of India s recently approved Production Linked Incentive (PLI) for the Pharmaceutical Sector. Government of India s Department of Pharmaceuticals under the Ministry of Chemicals and Fertilizers recently launched a Production Linked Incentive (PLI) Scheme to promote domestic manufacturing by incentivising pharmaceutical manufacturers to set-up greenfield projects in India with a minimum domestic value addition in four different target segments (Two in Fermentation based - at least 90% and Two in the Chemical Synthesis based - at least 70%) with a total outlay of Rs. 6,940 crores. The objective of the scheme is achieving self-reliance and reducing import dependence in these critical Key Starting Materials (KSMs)/ Drug Intermediates/ Active Pharmaceutical Ingredients (APIs) in the country. ....
Read more about Sensex closes almost flat, Nifty fails to reclaim 15,000 on Business Standard. Domestic equity benchmarks ended with small gains on Monday. Banks, IT, metals and pharma stocks advanced while autos, financials and FMCG shares declined. The Nifty closed near the 15,000 mark. ....
Aarti Speciality Chemicals Limited receives an approval accorded under PLI Scheme for Pharmaceutical Sector Posted On: 2021-03-06 04:25:29 (Time Zone: Arizona, USA) Aarti Speciality Chemicals Limited (ASCL), a wholly-owned subsidiary of Aarti Drugs Limited (Aarti Drugs), stands out to be one of the beneficiaries of the Government of India s recently approved Production Linked Incentive (PLI) for the Pharmaceutical Sector. Government of India s Department of Pharmaceuticals under the Ministry of Chemicals and Fertilizers recently launched a Production Linked Incentive (PLI) Scheme to promote domestic manufacturing by incentivising pharmaceutical manufacturers to set-up greenfield projects in India with a minimum domestic value addition in four different target segments (Two in Fermentation based - at least 90% and Two in the Chemical Synthesis based - at least 70%) with a total outlay of Rs. 6,940 crores. The objective of the scheme is achieving self-relian ....